Cargando…

Metastatic Medullary Thyroid Carcinoma and Cabozantinib: Case Series and Review of Literature

Cabozantinib, a tyrosine kinase inhibitor, was approved by the US Food and Drug Administration in November 2012, for the treatment of metastatic medullary thyroid carcinoma. Although side effects typically include stomatitis, palmar-plantar erythrodysesthesia syndrome, hypertension and diarrhea, mos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kapur, Sakshi, Xiao, Han, Zakowski, Maureen F., Hameed, Meera R., Levin, Miles B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649879/ https://www.ncbi.nlm.nih.gov/pubmed/29147383 http://dx.doi.org/10.14740/wjon779w

Ejemplares similares

Cabozantinib for the Treatment of Metastatic Medullary Thyroid Carcinoma
por: Nix, Nancy M., et al.
Publicado: (2014)

Cabozantinib for progressive metastatic medullary thyroid cancer: a review
por: Colombo, Joshua R, et al.
Publicado: (2014)

Profile of cabozantinib and its potential in the treatment of advanced medullary thyroid cancer
por: Hart, Christopher D, et al.
Publicado: (2013)

Vandetanib versus Cabozantinib in Medullary Thyroid Carcinoma: A Focus on Anti-Angiogenic Effects in Zebrafish Model
por: Carra, Silvia, et al.
Publicado: (2021)

Primary Malignant Mixed Müllerian Mesodermal Tumor Mimicking a Rectosigmoid Carcinoma: A Case Report and Review of the Literature
por: Kapur, Sakshi, et al.
Publicado: (2014)

Medullary carcinoma of the thyroid metastatic to the breast: a case report and literature review
por: Martins, Sebastião Nunes, et al.
Publicado: (2014)

Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma
por: Schlumberger, M, et al.
Publicado: (2017)

Metastatic medullary thyroid carcinoma: A case report
por: Niafar, Mitra, et al.
Publicado: (2011)

Medullary Thyroid Carcinoma Presenting as Metastatic Disease to the Breast
por: Kanteti, Archana P., et al.
Publicado: (2020)

Medullary thyroid carcinoma (MTC): unusual metastatic sites
por: Kazakou, Paraskevi, et al.
Publicado: (2021)

A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer
por: Capdevila, Jaume, et al.
Publicado: (2022)

Pazopanib, Cabozantinib, and Vandetanib in the Treatment of Progressive Medullary Thyroid Cancer with a Special Focus on the Adverse Effects on Hypertension
por: Milling, Rikke Vilsbøll, et al.
Publicado: (2018)

Precursor T-Cell Lymphoblastic Lymphoma Presenting as Cardiac Tamponade in a 25-Year-Old Male: A Case Report and Review of Literature
por: Kapur, Sakshi, et al.
Publicado: (2014)

Cabozantinib, Vandetanib, Pralsetinib and Selpercatinib as Treatment for Progressed Medullary Thyroid Cancer with a Main Focus on Hypertension as Adverse Effect
por: Højer Wang, Linnea, et al.
Publicado: (2023)

Metastatic medullary thyroid carcinoma presenting as ectopic Cushing’s syndrome
por: Forde, Hannah E, et al.
Publicado: (2021)

Metastatic medullary thyroid carcinoma: a new way forward
por: Angelousi, Anna, et al.
Publicado: (2022)

Transformation of Follicular Lymphoma to Double Hit B-Cell Lymphoma Causing Hypercalcemia in a 69-Year-Old Female: A Case Report and Review of the Literature
por: Kapur, Sakshi, et al.
Publicado: (2014)

Initial Experiences of Selective RET Inhibitor Selpercatinib in Adults with Metastatic Differentiated Thyroid Carcinoma and Medullary Thyroid Carcinoma: Real-World Case Series in Korea
por: Baek, Han-Sang, et al.
Publicado: (2023)

Thyroid: Medullary Carcinoma
por: Somnay, Yash R., et al.
Publicado: (2013)

A Case of Malignant Metastatic Pheochromocytoma After Eight Years of Primary Diagnosis
por: Kapur, Sakshi, et al.
Publicado: (2014)

Cabozantinib for the Management of Metastatic Clear Cell Renal Cell Carcinoma
por: Vecchio, Sharon J. Del, et al.
Publicado: (2018)

Sorafenib in Japanese Patients with Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma
por: Ito, Yasuhiro, et al.
Publicado: (2017)

Is Encapsulated Medullary Thyroid Carcinoma Associated With a Better Prognosis? A Case Series and a Review of the Literature
por: Contarino, Andrea, et al.
Publicado: (2022)

Medullary Thyroid Carcinoma Surveillance Study: A Case-Series Registry
por: Hale, Paula M., et al.
Publicado: (2020)

Clinical Utility of Cabozantinib in the Treatment of Locally Advanced or Metastatic Differentiated Thyroid Carcinoma: Patient Selection and Reported Outcomes
por: Roof, Logan, et al.
Publicado: (2023)

Simultaneous occurrence of medullary and papillary thyroid microcarcinomas: a case series and review of the literature
por: Adnan, Zaina, et al.
Publicado: (2013)

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
por: Degrauwe, Nils, et al.
Publicado: (2012)

Medullary carcinoma of the thyroid gland.
por: Russell, C.
Publicado: (1980)

Medullary carcinoma of the thyroid: an update
por: Alevizaki, Maria
Publicado: (2013)

Pediatric Medullary Thyroid Carcinoma
por: Starenki, Dmytro, et al.
Publicado: (2015)

Diagnosing a Gastric Submucosal Tumor Using Jumbo Biopsy “Unroofing” Technique: A Case Report and Review of the Literature
por: Kapur, Sakshi, et al.
Publicado: (2013)

Cabozantinib in metastatic renal cell carcinoma: latest findings and clinical potential
por: Bersanelli, Melissa, et al.
Publicado: (2017)

Antitumor Effect of Cabozantinib in Bone Metastatic Models of Renal Cell Carcinoma
por: Iuliani, Michele, et al.
Publicado: (2021)

Cabozantinib‐nivolumab sequence in metastatic renal cell carcinoma: The CABIR study
por: Vano, Yann‐Alexandre, et al.
Publicado: (2022)

Weight and skeletal muscle loss with cabozantinib in metastatic renal cell carcinoma
por: Colomba, Emeline, et al.
Publicado: (2022)

Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas
por: Thouvenin, Jonathan, et al.
Publicado: (2022)

Not all that is miliary is tuberculosis: Metastatic medullary thyroid carcinoma mimicking miliary tuberculosis
por: Askari, Elham, et al.
Publicado: (2021)

Three siblings with familial non-medullary thyroid carcinoma: a case series
por: Rashid, Muhammad Owais, et al.
Publicado: (2016)

Treatment of medullary thyroid carcinoma with apatinib: A case report and literature review
por: Cai, Sina, et al.
Publicado: (2017)

Mixed medullary‑follicular thyroid carcinoma: A case report and literature review
por: Wang, Yonghui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6neb32oninsof3b470vece5mq8